Skip to main content
Veterinary Medicines

Calciveyxol 38 infúzny roztok

Authorised
  • Magnesium hypophosphite hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION
  • Boric acid

Product identification

Medicine name:
Calciveyxol 38 infúzny roztok
Active substance:
  • Magnesium hypophosphite hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION
  • Boric acid
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Magnesium hypophosphite hexahydrate
    60.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • CALCIUM GLUCONATE FOR INJECTION
    380.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Boric acid
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Available in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/049/05-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 17/12/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."